Safety of Virtual Reality(VR) experiences in patients after hematopoietic stem cell transplantation in clean room or semi-clean room

Safety of Virtual Reality(VR) experiences in patients after hematopoietic stem cell transplantation in clean room or semi-clean room - Safety of Virtual Reality(VR) experiences in patients after hematopoietic stem cell transplantation in clean room or semi-clean room

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000046090

Enrollment

Registered

2022-01-20

Start date

2022-09-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematopoietic tumor

Interventions

Wearing the Head-Mounted Display and experiencing VR for about 15 minutes

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients after hematopoietic stem cell transplantation in clean room or semi-clean room Experience VR within a week from 3 days after engraftment

Exclusion criteria

Exclusion criteria: Decreased mental and cognitive function Wounds and skin symptoms on the head Eye symptoms Visual perception disorders other than myopia, hyperopia, astigmatism, etc. Difficulty wearing the Head-Mounted Display and operating the controllers History of epilepsy

Design outcomes

Primary

Measure	Time frame
Simulator Sickness Questionnaire (at before, immediately after, 30minutes after the VR experience)	—

Secondary

Measure	Time frame
salivary alpha-amylase activity (at before, immediately after, 30minutes after the VR experience) Edmonton Symptom Assessment System Revised Japanese version (at before, immediately after, 30minutes after the VR experience)	—

Countries

Japan

Contacts

Public ContactNaoko Okawa

Kobe University Hospital Medical Technology Department

okawa@med.kobe-u.ac.jp075-382-6493

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026